Literature DB >> 10406793

Structural basis for the specificity of ubiquitin C-terminal hydrolases.

S C Johnston1, S M Riddle, R E Cohen, C P Hill.   

Abstract

The release of ubiquitin from attachment to other proteins and adducts is critical for ubiquitin biosynthesis, proteasomal degradation and other cellular processes. De-ubiquitination is accomplished in part by members of the UCH (ubiquitin C-terminal hydrolase) family of enzymes. We have determined the 2.25 A resolution crystal structure of the yeast UCH, Yuh1, in a complex with the inhibitor ubiquitin aldehyde (Ubal). The structure mimics the tetrahedral intermediate in the reaction pathway and explains the very high enzyme specificity. Comparison with a related, unliganded UCH structure indicates that ubiquitin binding is coupled to rearrangements which block the active-site cleft in the absence of authentic substrate. Remarkably, a 21-residue loop that becomes ordered upon binding Ubal lies directly over the active site. Efficiently processed substrates apparently pass through this loop, and constraints on the loop conformation probably function to control UCH specificity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10406793      PMCID: PMC1171464          DOI: 10.1093/emboj/18.14.3877

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  112 in total

1.  Divergent N-terminal sequences target an inducible testis deubiquitinating enzyme to distinct subcellular structures.

Authors:  H Lin; A Keriel; C R Morales; N Bedard; Q Zhao; P Hingamp; S Lefrançois; L Combaret; S S Wing
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Tissue-specificity, functional characterization and subcellular localization of a rat ubiquitin-specific processing protease, UBP109, whose mRNA expression is developmentally regulated.

Authors:  K C Park; E J Choi; S W Min; S S Chung; H Kim; T Suzuki; K Tanaka; C H Chung
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

3.  Deubiquitinating function of adenovirus proteinase.

Authors:  Maxim Y Balakirev; Michel Jaquinod; Arthur L Haas; Jadwiga Chroboczek
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Otubains: a new family of cysteine proteases in the ubiquitin pathway.

Authors:  Maxim Y Balakirev; Sergey O Tcherniuk; Michel Jaquinod; Jadwiga Chroboczek
Journal:  EMBO Rep       Date:  2003-05       Impact factor: 8.807

5.  A conserved catalytic residue in the ubiquitin-conjugating enzyme family.

Authors:  Pei-Ying Wu; Mary Hanlon; Michael Eddins; Colleen Tsui; Richard S Rogers; Jane P Jensen; Michael J Matunis; Allan M Weissman; Allan M Weisman; Allan M Weissman; Cynthia Wolberger; Cynthia P Wolberger; Cecile M Pickart
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

6.  Crystal structure of human otubain 2.

Authors:  Max H Nanao; Sergey O Tcherniuk; Jadwiga Chroboczek; Otto Dideberg; Andréa Dessen; Maxim Y Balakirev
Journal:  EMBO Rep       Date:  2004-07-16       Impact factor: 8.807

7.  A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8.

Authors:  Danny T Huang; David W Miller; Rose Mathew; Robert Cassell; James M Holton; Martine F Roussel; Brenda A Schulman
Journal:  Nat Struct Mol Biol       Date:  2004-09-07       Impact factor: 15.369

8.  An efficient system for high-level expression and easy purification of authentic recombinant proteins.

Authors:  Ann-Maree Catanzariti; Tatiana A Soboleva; David A Jans; Philip G Board; Rohan T Baker
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

9.  Structural characterization of human Uch37.

Authors:  Sethe E Burgie; Craig A Bingman; Ameet B Soni; George N Phillips
Journal:  Proteins       Date:  2011-09-26

10.  Weak conservation of structural features in the interfaces of homologous transient protein-protein complexes.

Authors:  Govindarajan Sudha; Prashant Singh; Lakshmipuram S Swapna; Narayanaswamy Srinivasan
Journal:  Protein Sci       Date:  2015-09-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.